Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ADAP - Adaptimmune Therapeutics plc
177 M
LAST VALUE
52.61%
2 YEAR CAGR
64.68%
5 YEAR CAGR
101.58%
10 YEAR CAGR